Search research articles
Contact Us
Filters
Showing results (41-50 of 53) with videos related to
Page
of 6
Sort By:
RMD Open
|
November 8, 2018
Antiphospholipid syndrome: state of the art on clinical practice guidelines
Marteen Limper, Carlo Alberto Scirè, Rosaria Talarico, et al.
Mediterranean Journal of Rheumatology
|
March 19, 2020
Multicenter Cross-sectional Study of Patients with Rheumatoid Arthritis in Greece: Results from a cohort of 2.491 patients
Konstantinos Thomas, Argiro Lazarini, Evripidis Kaltsonoudis, et al.
Journal of Thrombosis and Haemostasis : JTH
|
August 1, 2019
Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository
Maria Efthymiou, Ian J Mackie, Philip J Lane, et al.
Annals of the Rheumatic Diseases
|
August 2, 2012
Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
George K Bertsias, Maria Tektonidou, Zahir Amoura, et al.
Arthritis Care & Research
|
July 7, 2025
Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-C Report: Assessment of Patient Scenarios (Derivation Cohort) and Refinement of Definitions
Medha Barbhaiya, Stephane Zuily, Deanna Jannat-Khah, et al.
RMD Open
|
December 20, 2018
Systemic lupus erythematosus: state of the art on clinical practice guidelines
Farah Tamirou, Laurent Arnaud, Rosaria Talarico, et al.
Clinical and Experimental Rheumatology
|
March 14, 2023
ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products
Rosaria Talarico, Giuseppe Alvise Ramirez, Sofia C Barreira, et al.
Seminars in Arthritis and Rheumatism
|
September 5, 2022
Efficacy and safety of tocilizumab in adult-onset Still's disease: Real-life experience from the international AIDA registry
Jurgen Sota, Antonio Vitale, Giuseppe Lopalco, et al.
Seminars in Arthritis and Rheumatism
|
July 30, 2023
The administration of methotrexate in patients with Still's disease, "real-life" findings from AIDA Network Still Disease Registry
Piero Ruscitti, Jurgen Sota, Antonio Vitale, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
March 19, 2024
The Systemic Score May Identify Life-Threatening Evolution in Still Disease: Data from the GIRRCS AOSD-Study Group and the AIDA Network Still Disease Registry
Piero Ruscitti, Francesco Masedu, Antonio Vitale, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 53) with videos related to
Sort By:
Page
of 6
RMD Open
|
November 8, 2018
Antiphospholipid syndrome: state of the art on clinical practice guidelines
Marteen Limper, Carlo Alberto Scirè, Rosaria Talarico, et al.
Mediterranean Journal of Rheumatology
|
March 19, 2020
Multicenter Cross-sectional Study of Patients with Rheumatoid Arthritis in Greece: Results from a cohort of 2.491 patients
Konstantinos Thomas, Argiro Lazarini, Evripidis Kaltsonoudis, et al.
Journal of Thrombosis and Haemostasis : JTH
|
August 1, 2019
Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository
Maria Efthymiou, Ian J Mackie, Philip J Lane, et al.
Annals of the Rheumatic Diseases
|
August 2, 2012
Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
George K Bertsias, Maria Tektonidou, Zahir Amoura, et al.
Arthritis Care & Research
|
July 7, 2025
Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-C Report: Assessment of Patient Scenarios (Derivation Cohort) and Refinement of Definitions
Medha Barbhaiya, Stephane Zuily, Deanna Jannat-Khah, et al.
RMD Open
|
December 20, 2018
Systemic lupus erythematosus: state of the art on clinical practice guidelines
Farah Tamirou, Laurent Arnaud, Rosaria Talarico, et al.
Clinical and Experimental Rheumatology
|
March 14, 2023
ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products
Rosaria Talarico, Giuseppe Alvise Ramirez, Sofia C Barreira, et al.
Seminars in Arthritis and Rheumatism
|
September 5, 2022
Efficacy and safety of tocilizumab in adult-onset Still's disease: Real-life experience from the international AIDA registry
Jurgen Sota, Antonio Vitale, Giuseppe Lopalco, et al.
Seminars in Arthritis and Rheumatism
|
July 30, 2023
The administration of methotrexate in patients with Still's disease, "real-life" findings from AIDA Network Still Disease Registry
Piero Ruscitti, Jurgen Sota, Antonio Vitale, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
March 19, 2024
The Systemic Score May Identify Life-Threatening Evolution in Still Disease: Data from the GIRRCS AOSD-Study Group and the AIDA Network Still Disease Registry
Piero Ruscitti, Francesco Masedu, Antonio Vitale, et al.
Page
of 6